Fidelis Capital Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.04M | Buy |
16,314
+2,628
| +19% | +$167K | 0.09% | 168 |
|
2025
Q1 | $894K | Buy |
13,686
+7,410
| +118% | +$484K | 0.1% | 169 |
|
2024
Q4 | $351K | Sell |
6,276
-1,010
| -14% | -$56.5K | 0.04% | 309 |
|
2024
Q3 | $414K | Sell |
7,286
-11,181
| -61% | -$635K | 0.05% | 264 |
|
2024
Q2 | $1.04M | Sell |
18,467
-4,132
| -18% | -$233K | 0.15% | 132 |
|
2024
Q1 | $1.8M | Buy |
22,599
+4,870
| +27% | +$388K | 0.27% | 73 |
|
2023
Q4 | $1.4M | Buy |
17,729
+6,357
| +56% | +$502K | 0.31% | 68 |
|
2023
Q3 | $796K | Buy |
11,372
+1,585
| +16% | +$111K | 0.27% | 79 |
|
2023
Q2 | $677K | Buy |
9,787
+775
| +9% | +$53.6K | 0.25% | 97 |
|
2023
Q1 | $637K | Buy |
9,012
+5,662
| +169% | +$400K | 0.27% | 94 |
|
2022
Q4 | $306K | Buy |
+3,350
| New | +$306K | 0.36% | 79 |
|